For the quarter ending 2025-09-30, RNGE had $237,076 increase in cash & cash equivalents over the period.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net insurance proceeds from casualty loss | 0 | - |
| Net proceeds from disposition of graphium biosciences | 0 | - |
| Equipment purchases | 0 | 100,000 |
| Proceeds from asset sales | 120,500 | 404,500 |
| Cash paid for asset retirement obligations | 338,528 | 415,338 |
| Net cash provided by (used in) investing activities | -218,028 | -110,838 |
| Issuance of shares for cash | 550,000 | 600,000 |
| Repayment of line of credit | 0 | 200,000 |
| Repayment of long-term debt | 0 | 522,143 |
| Net cash provided by (used in) financing activities | 550,000 | -122,143 |
| Net loss on collins building disposal | 0 | - |
| Net loss on sale of assets | 0 | - |
| Gain on disposition of business | 0 | - |
| Deposits from discontinued operations | 0 | - |
| Net gain on asset disposals | 1,085 | - |
| Fair value of vested stock options | 0 | 168,980 |
| Accretion on asset retirement obligations | 719,912 | 524,033 |
| Accounts receivable | 212,768 | 6,653 |
| Unbilled receivables | -22,813 | - |
| Contract assets | 0 | -154,354 |
| Prepaid expenses and other current assets | -14,465 | 38,639 |
| Inventory | - | 0 |
| Deposits | 10,258 | 5,137 |
| Accounts payable | -3,935 | -53,416 |
| Accrued expenses | -41,665 | 11,746 |
| Gain on bargain purchase | 0 | 5,602,484 |
| Deficiency claim on returned equipment | 0 | 560,402 |
| Net gain on asset disposals | - | 25,668 |
| Net income (loss) | -633,381 | 4,301,446 |
| Depreciation | 25,338 | 125,043 |
| Net cash provided by (used in) operating activities | -94,896 | 114,007 |
| Net increase (decrease) in cash and cash equivalents | 237,076 | -118,974 |
| Cash and cash equivalents at beginning of period | 167,286 | - |
| Cash and cash equivalents at end of period | 285,388 | - |
RANGE IMPACT, INC. (RNGE)
RANGE IMPACT, INC. (RNGE)